178 related articles for article (PubMed ID: 11102958)
1. Detection and analysis of beta-catenin mutations in prostate cancer.
Chesire DR; Ewing CM; Sauvageot J; Bova GS; Isaacs WB
Prostate; 2000 Dec; 45(4):323-34. PubMed ID: 11102958
[TBL] [Abstract][Full Text] [Related]
2. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma.
Omholt K; Platz A; Ringborg U; Hansson J
Int J Cancer; 2001 Jun; 92(6):839-42. PubMed ID: 11351304
[TBL] [Abstract][Full Text] [Related]
4. beta-catenin expression and mutational analysis in renal cell carcinomas.
Kim YS; Kang YK; Kim JB; Han SA; Kim KI; Paik SR
Pathol Int; 2000 Sep; 50(9):725-30. PubMed ID: 11012986
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.
Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787
[TBL] [Abstract][Full Text] [Related]
6. Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines.
Woo DK; Kim HS; Lee HS; Kang YH; Yang HK; Kim WH
Int J Cancer; 2001 Mar; 95(2):108-13. PubMed ID: 11241321
[TBL] [Abstract][Full Text] [Related]
7. Analysis of beta-catenin mutations and alpha-, beta-, and gamma-catenin expression in normal and neoplastic human pituitary tissues.
Tziortzioti V; Ruebel KH; Kuroki T; Jin L; Scheithauer BW; Lloyd RV
Endocr Pathol; 2001; 12(2):125-36. PubMed ID: 11579678
[TBL] [Abstract][Full Text] [Related]
8. Activation of the beta-catenin gene by interstitial deletions involving exon 3 as an early event in colorectal tumorigenesis.
Murata M; Iwao K; Miyoshi Y; Nagasawa Y; Yabu M; Himeno S; Imanishi K; Ohsawa M; Wada H; Tominaga S; Shimano T; Kobayashi T; Nakamura Y
Cancer Lett; 2000 Oct; 159(1):73-8. PubMed ID: 10974408
[TBL] [Abstract][Full Text] [Related]
9. Analysis of beta-catenin gene mutations in pancreatic tumors.
Gerdes B; Ramaswamy A; Simon B; Pietsch T; Bastian D; Kersting M; Moll R; Bartsch D
Digestion; 1999; 60(6):544-8. PubMed ID: 10545724
[TBL] [Abstract][Full Text] [Related]
10. Alterations of E-cadherin and beta-catenin in gastric cancer.
Huiping C; Kristjansdottir S; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S
BMC Cancer; 2001; 1():16. PubMed ID: 11747475
[TBL] [Abstract][Full Text] [Related]
11. Frequent alterations of the beta-catenin protein in cancer of the uterine cervix.
Pereira-Suárez AL; Meraz MA; Lizano M; Estrada-Chávez C; Hernández F; Olivera P; Pérez E; Padilla P; Yaniv M; Thierry F; García-Carrancá A
Tumour Biol; 2002; 23(1):45-53. PubMed ID: 11893906
[TBL] [Abstract][Full Text] [Related]
12. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.
Pierceall WE; Woodard AS; Morrow JS; Rimm D; Fearon ER
Oncogene; 1995 Oct; 11(7):1319-26. PubMed ID: 7478552
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the beta-catenin gene in gastric carcinomas.
Sasaki Y; Morimoto I; Kusano M; Hosokawa M; Itoh F; Yanagihara K; Imai K; Tokino T
Tumour Biol; 2001; 22(2):123-30. PubMed ID: 11125285
[TBL] [Abstract][Full Text] [Related]
14. Beta-catenin mutations in human prostate cancer.
Voeller HJ; Truica CI; Gelmann EP
Cancer Res; 1998 Jun; 58(12):2520-3. PubMed ID: 9635571
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.
Koch A; Waha A; Tonn JC; Sörensen N; Berthold F; Wolter M; Reifenberger J; Hartmann W; Friedl W; Reifenberger G; Wiestler OD; Pietsch T
Int J Cancer; 2001 Aug; 93(3):445-9. PubMed ID: 11433413
[TBL] [Abstract][Full Text] [Related]
16. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
de la Taille A; Rubin MA; Chen MW; Vacherot F; de Medina SG; Burchardt M; Buttyan R; Chopin D
Clin Cancer Res; 2003 May; 9(5):1801-7. PubMed ID: 12738737
[TBL] [Abstract][Full Text] [Related]
17. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
[TBL] [Abstract][Full Text] [Related]
18. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.
Chesire DR; Ewing CM; Gage WR; Isaacs WB
Oncogene; 2002 Apr; 21(17):2679-94. PubMed ID: 11965541
[TBL] [Abstract][Full Text] [Related]
19. Frequent beta-catenin overexpression without exon 3 mutation in cutaneous lymphomas.
Bellei B; Pacchiarotti A; Perez M; Faraggiana T
Mod Pathol; 2004 Oct; 17(10):1275-81. PubMed ID: 15195109
[TBL] [Abstract][Full Text] [Related]
20. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R
Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]